EDGAR Filing Documents for 0001683168-17-002356

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001683168-17-002356

Filing Date

2017-09-13

Accepted

2017-09-13 09:25:34

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3	pharmacyte_s3-091117.htm	S-3	312254
2	INDENTURE	pharmacyte_s3-ex0401.htm	EX-4.1	304142
3	INDENTURE	pharmacyte_s3-ex0403.htm	EX-4.3	336526
4	OPINION	pharmacyte_s3-ex0501.htm	EX-5.1	42829
5	CONSENT	pharmacyte_s3-ex2301.htm	EX-23.1	2174
6	GRAPHIC	image_001.jpg	GRAPHIC	5900
7	GRAPHIC	image_002.jpg	GRAPHIC	8006
8	GRAPHIC	image_003.jpg	GRAPHIC	6920
9	GRAPHIC	image_004.jpg	GRAPHIC	6920
10	GRAPHIC	image_005.jpg	GRAPHIC	6920
11	GRAPHIC	image_006.jpg	GRAPHIC	6920
12	GRAPHIC	image_007.jpg	GRAPHIC	6920
13	GRAPHIC	ex2301_logo.jpg	GRAPHIC	2584
14	GRAPHIC	image_001.gif	GRAPHIC	1472
	Complete submission text file	0001683168-17-002356.txt		1072619

Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653

Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850

PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)